Drug Metabolism and Pharmacokinetics
Online ISSN : 1880-0920
Print ISSN : 1347-4367
ISSN-L : 1347-4367

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Establishment of MDCKII Cell Monolayer with Metabolic Activity by CYP3A4 Transduced with Recombinant Adenovirus
Makoto KataokaYuki TerashimaKatsuhiko MizunoYoshie MasaokaShinji SakumaTsuyoshi YokoiShinji Yamashita
著者情報
ジャーナル フリー 早期公開

論文ID: DMPK-12-RG-059

この記事には本公開記事があります。
詳細
抄録
  This study aims to establish an in vitro system that can assess intestinal first-pass metabolism of CYP3A4 substrate drugs using adenoviral transduction. Madin-Darby canine kidney II (MDCKII) cells were used as a model of intestinal epithelial cells. Recombinant adenovirus expressing green fluorescent protein (AdGFP) and CYP3A4 (AdCYP3A4) was used as vectors. On day 2 after seeding MDCKII cells onto semipermeable membrane, cells were infected with each adenovirus vector at various MOIs (multiplicities of infection) ranging from 0 to 200. On day 5, cell monolayers were used for drug transport study. The expression of GFP in monolayers of MDCKII cells transduced with AdGFP increased MOI-dependently and adenoviral infection showed no effect on the membrane permeability of drugs. The metabolite formation rate of midazolam, a CYP3A4 substrate, in the permeation process of a monolayer linearly increased with an increase in the MOI of AdCYP3A4. When the period that vectors and cells were located adjacent to each other was prolonged, the rate increased 2-fold compared with that calculated from a result with a monolayer obtained from a shorter period of adjacency. This study indicates that monolayers of MDCKII cells transduced with AdCYP3A4 have the potential to enable estimation of the first-pass metabolism by CYP3A4 in the intestinal absorption process.
著者関連情報

この記事は最新の被引用情報を取得できません。

© 2012 by The Japanese Society for the Study of Xenobiotics
feedback
Top